Other proteins in the antigen presentation process, such as β2-microglobulin, are also often downregulated in tumor cells, leading to unstable expression of MHC molecules on the cell surface and further reducing the chances of tumor cells being recognized by the immune system (79). This evidence concerns the gene HLA-C and neoplasm.